2013ÔÇÖs best performing IPOs (so far)

6. Alcobra Ltd (ADHD)

Gain: 156%
Offer price: $8
Recent close: $20
Offer date: 21-May-2013
www.alcobra-pharma.com

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of various drugs for the treatment of neurological disturbance. Its principal product includes MG01CI that has completed Phase II studies to treat attention deficit hyperactivity disorder. The company was founded in 2008 and is headquartered in Tel Aviv, Israel.